Zhitong Finance App News, Cornerstone Pharmaceutical-B (02616) issued an announcement. On March 28, 2024, the board of directors of the company decided to grant a total of 11.1979 million restricted share units to 104 restricted share unit grantees in accordance with the restricted share award scheme after the initial public offering.
On March 28, 2024, the board of directors of the company decided to grant a total of 11.202,900 share options to 107 share option grantees in accordance with the post-initial public offering employee share ownership plan.